[Pharmacologic advantages of individual cholesterol synthesis inhibitors? Prof. Dr. Dr. med. W. Schunack, Free University Berlin, elaborates on differential therapeutic considerations].
Schunack
W
W
D002784:Cholesterol / Q000097:blood*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D011355:Prodrugs / Q000493:pharmacokinetics / Q000627:therapeutic use*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011355:Prodrugs; D002784:Cholesterol
Pharmakologische Vorzüge einzelner CSE-Hemmer?Prof. Dr. Dr. med. W. Schunack, Freie Universität Berlin, erläutert differentialtherapeutische Uberlegungen.